Popular Remedies for Esophageal Symptoms: a Critical Appraisal

  • Amisha Ahuja
  • Nitin K. AhujaEmail author
Esophagus (J Clarke and N Ahuja, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Esophagus


Purpose of Review

Popular remedies are of ongoing interest to patients experiencing common esophageal symptoms, particularly as typical pharmacologic interventions have been subject to increased scrutiny. Herein we summarize the available data regarding potential risks and benefits of several such remedies.

Recent Findings

With emphasis on reflux and non-cardiac chest pain, research is ongoing into the clinical utility and diverse physiologic mechanisms underlying a variety of complementary and alternative modalities, including dietary manipulation, apple cider vinegar, melatonin, acupuncture, and various herbal products (rikkunshito, STW 5, slippery elm, licorice, and peppermint oil, among others).


A substantial gap persists between anecdotal and empirical understandings of the majority of non-pharmacologic remedies for esophageal symptoms. This landscape of popular treatments nevertheless raises several interesting mechanistic hypotheses and compelling opportunities for future research.


Heartburn GERD NCCP Diet Nutrition Complementary Alternative CAM 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Barnes PM, Bloom B, Nahin R. CDC National Health Statistics Report #12. Complementary and alternative medicine use among adults and children: United States, 2007 2008 [cited 2019 April 20]. Available from: 20 April 2019
  2. 2.
    • Yoon SL, Grundmann O, Smith KF, Mason SR. Dietary supplement and complementary and alternative medicine use are highly prevalent in patients with gastrointestinal disorders: results from an online survey. J Diet Suppl. 2018;29:1–14. A recent internet-based survey revealed a high prevalence (84%) of use of dietary supplements and complementary and alternative medicine among respondents with a history of gastrointestinal symptoms. CrossRefGoogle Scholar
  3. 3.
    Astin JA. Why patients use alternative medicine: results of a national study. Jama. 1998;279(19):1548–53.PubMedCrossRefGoogle Scholar
  4. 4.
    Hung A, Kang N, Bollom A, Wolf JL, Lembo A. Complementary and alternative medicine use is prevalent among patients with gastrointestinal diseases. Dig Dis Sci. 2015;60(7):1883–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology. 2017;153(1):35–48.PubMedCrossRefGoogle Scholar
  6. 6.
    El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun;63(6):871–80.PubMedCrossRefGoogle Scholar
  7. 7.
    Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28 quiz 29.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol : the official clinical practice journal of the American Gastroenterological Association. 2016;14(2):175–82 e1–3.CrossRefGoogle Scholar
  9. 9.
    Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006;166(9):965–71.PubMedCrossRefGoogle Scholar
  10. 10.
    Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976;21(11):953–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Feldman M, Barnett C. Relationships between the acidity and osmolality of popular beverages and reported postprandial heartburn. Gastroenterology. 1995;108(1):125–31.CrossRefGoogle Scholar
  12. 12.
    Pointer SD, Rickstrew J, Slaughter JC, Vaezi MF, Silver HJ. Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in European- and African-American obese women. Aliment Pharmacol Ther. 2016;44(9):976–88.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Austin GL, Thiny MT, Westman EC, Yancy WS Jr, Shaheen NJ. A very low-carbohydrate diet improves gastroesophageal reflux and its symptoms. Dig Dis Sci. 2006;51(8):1307–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Morozov S, Isakov V, Konovalova M. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease. World J Gastroenterol. 2018;24(21):2291–9.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Gibson PR. History of the low FODMAP diet. J Gastroenterol Hepatol. 2017;32 Suppl 1:5–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Nam SY, Park BJ, Cho YA, Ryu KH, Choi IJ, Park S, et al. Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects. J Gastroenterol. 2017;52(7):818–29.PubMedCrossRefGoogle Scholar
  17. 17.
    Mano F, Ikeda K, Sato T, Nakayama T, Tanaka D, Joo E, et al. Reduction in gastroesophageal reflux disease symptoms is associated with miso soup intake in a population-based cross-sectional study: the Nagahama study. J Nutr Sci Vitaminol. 2018;64(5):367–73.PubMedCrossRefGoogle Scholar
  18. 18.
    Nam SY, Park BJ, Cho YA, Ryu KH. Gender-specific effect of micronutrient on non-erosive reflux disease and erosive esophagitis. J Neurogastroenterol Motility. 2019;25(1):82–90.CrossRefGoogle Scholar
  19. 19.
    Mano F, Ikeda K, Joo E, Yamane S, Harada N, Inagaki N. Effects of three major amino acids found in Japanese broth on glucose metabolism and gastric emptying. Nutrition. 2018;46:153–8 e1.PubMedCrossRefGoogle Scholar
  20. 20.
    Hill LL, Woodruff LH, Foote JC, Barreto-Alcoba M. Esophageal injury by apple cider vinegar tablets and subsequent evaluation of products. J Am Diet Assoc. 2005;105(7):1141–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Johnston CS, White AM, Kent SM. A preliminary evaluation of the safety and tolerance of medicinally ingested vinegar in individuals with type 2 diabetes. J Med Food. 2008;11(1):179–83.PubMedCrossRefGoogle Scholar
  22. 22.
    Hlebowicz J, Darwiche G, Bjorgell O, Almer LO. Effect of apple cider vinegar on delayed gastric emptying in patients with type 1 diabetes mellitus: a pilot study. BMC Gastroenterol. 2007;20(7):46.CrossRefGoogle Scholar
  23. 23.
    Petsiou EI, Mitrou PI, Raptis SA, Dimitriadis GD. Effect and mechanisms of action of vinegar on glucose metabolism, lipid profile, and body weight. Nutr Rev. 2014;72(10):651–61.PubMedCrossRefGoogle Scholar
  24. 24.
    Yagnik D, Serafin V, Shah AJ. Antimicrobial activity of apple cider vinegar against Escherichia coli, Staphylococcus aureus and Candida albicans; downregulating cytokine and microbial protein expression. Sci Rep. 2018;8(1):1732.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Brown R, Sam CH, Green T, Wood S. Effect of GutsyGum(tm), a novel gum, on subjective ratings of gastro esophageal reflux following a refluxogenic meal. J Diet Suppl. 2015;12(2):138–45.CrossRefGoogle Scholar
  26. 26.
    Yeh Z. Is apple cider vinegar effective for reducing heartburn symptoms related to gastroesophageal reflux disease?: Arizona State University; 2016.Google Scholar
  27. 27.
    Langella C, Naviglio D, Marino M, Calogero A, Gallo M. New food approaches to reduce and/or eliminate increased gastric acidity related to gastroesophageal pathologies. Nutrition. 2018;54:26–32.PubMedCrossRefGoogle Scholar
  28. 28.
    Kines K, Krupczak T. Nutritional interventions for gastroesophageal reflux, irritable bowel syndrome, and hypochlorhydria: a case report. Integr Med. 2016;15(4):49–53.Google Scholar
  29. 29.
    Majka J, Wierdak M, Brzozowska I, Magierowski M, Szlachcic A, Wojcik D, et al. Melatonin in prevention of the sequence from reflux esophagitis to Barrett’s esophagus and esophageal adenocarcinoma: experimental and clinical perspectives. Int J Mol Sci. 2018;19(7):E2033.CrossRefGoogle Scholar
  30. 30.
    Kandil TS, Mousa AA, El-Gendy AA, Abbas AM. The potential therapeutic effect of melatonin in gastro-esophageal reflux disease. BMC Gastroenterol. 2010;10:7.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Pereira RD. Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole. J Pineal Res. 2006;41(3):195–200.CrossRefGoogle Scholar
  32. 32.
    • Hoshino N, Nishizaki D, Hida K, Obama K, Sakai Y. Rikkunshito for upper gastrointestinal symptoms: a systematic review and meta-analysis. Compl Ther Med. 2019;42:255–63. The results of a recent meta-analysis of 24 studies involving rikkunshito yielded mixed results, with significant relief of upper gastrointestinal symptoms demonstrated by a 5-point symptom score but not by the Gastrointestinal Symptom Rating Scale. Interpretation is limited generally by significant study heterogeneity and specifically by a lack of focus on esophageal symptoms primarily. CrossRefGoogle Scholar
  33. 33.
    Tominaga K, Iwakiri R, Fujimoto K, Fujiwara Y, Tanaka M, Shimoyama Y, et al. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. J Gastroenterol. 2012;47(3):284–92.PubMedCrossRefGoogle Scholar
  34. 34.
    Tominaga K, Kato M, Takeda H, Shimoyama Y, Umegaki E, Iwakiri R, et al. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol. 2014;49(10):1392–405.PubMedCrossRefGoogle Scholar
  35. 35.
    Kawahara H, Kubota A, Hasegawa T, Okuyama H, Ueno T, Ida S, et al. Effects of rikkunshito on the clinical symptoms and esophageal acid exposure in children with symptomatic gastroesophageal reflux. Pediatr Surg Int. 2007;23(10):1001–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Yanai M, Mochiki E, Ogawa A, Morita H, Toyomasu Y, Ogata K, et al. Intragastric administration of rikkunshito stimulates upper gastrointestinal motility and gastric emptying in conscious dogs. J Gastroenterol. 2013;48(5):611–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Melzer J, Rosch W, Reichling J, Brignoli R, Saller R. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther. 2004;20(11–12):1279–87.PubMedCrossRefGoogle Scholar
  38. 38.
    Abdel-Aziz H, Zaki HF, Neuhuber W, Kelber O, Weiser D, Khayyal MT. Effect of an herbal preparation, STW 5, in an acute model of reflux oesophagitis in rats. J Pharmacol Sci. 2010;113(2):134–42.PubMedCrossRefGoogle Scholar
  39. 39.
    Allescher HD, Abdel-Aziz H. Mechanism of action of STW 5 in functional dyspepsia and IBS: the origin of multi-target. Dig Dis. 2017;35(Suppl 1):18–24.PubMedCrossRefGoogle Scholar
  40. 40.
    Ottillinger B, Storr M, Malfertheiner P, Allescher HD. STW 5 (Iberogast(R))—a safe and effective standard in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr. 2013;163(3–4):65–72.CrossRefGoogle Scholar
  41. 41.
    Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Greater Celandine hepatotoxicity: a clinical review. Ann Hepatol. 2012;11(6):838–48.PubMedCrossRefGoogle Scholar
  42. 42.
    Watts CR, Rousseau B. Slippery elm, its biochemistry, and use as a complementary and alternative treatment for laryngeal irritation. J Investig Biochem. 2010;1(1):17–23.CrossRefGoogle Scholar
  43. 43.
    Yang Y, Wang S, Bao YR, Li TJ, Yang GL, Chang X, et al. Anti-ulcer effect and potential mechanism of licoflavone by regulating inflammation mediators and amino acid metabolism. J Ethnopharmacol. 2017;199:175–82.PubMedCrossRefGoogle Scholar
  44. 44.
    Albermann ME, Musshoff F, Hagemeier L, Madea B. Determination of glycyrrhetic acid after consumption of liquorice and application to a fatality. Forensic Sci Int. 2010;197(1–3):35–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Tewari SN, Trembalowicz FC. Some experience with deglycyrrhizinated liquorice in the treatment of gastric and duodenal ulcers with special reference to its spasmolytic effect. Gut. 1968;9(1):48–51.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Engqvist A, Von Feilitzen F, Pyk E, Reichard H. Double-blind trial of deglycyrrhizinated liquorice in gastric ulcer. Gut. 1973;14(9):711–5.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Setright R. Prevention of symptoms of gastric irritation (GERD) using two herbal formulas: an observational study. J Austral Trad-Med Soc. 2017;23(2):68.Google Scholar
  48. 48.
    Sewing KF. Efficacy of low-dose antacids in the treatment of peptic ulcers: pharmacological explanation? J Clin Gastroenterol. 1991;13(Suppl 1):S134–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Young GP, Nagy GS, Myren J, Kronborg IJ, Logan KR, Reed PI, et al. Treatment of reflux oesophagitis with a carbenoxolone/antacid/alginate preparation. A double-blind controlled trial. Scand J Gastroenterol. 1986;21(9):1098–104.PubMedCrossRefGoogle Scholar
  50. 50.
    DiSilvestro RA, Verbruggen MA, Offutt EJ. Anti-heartburn effects of a fenugreek fiber product. Phytother Res : PTR. 2011;25(1):88–91.PubMedCrossRefGoogle Scholar
  51. 51.
    Ku SK, Seo BI, Park JH, Park GY, Seo YB, Kim JS, et al. Effect of Lonicerae Flos extracts on reflux esophagitis with antioxidant activity. World J Gastroenterol. 2009;15(38):4799–805.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Yarnell E, Abascal K. Herbs for gastroesophageal reflux disease. Alternative and Complementary Therapies. 2010;16(6):344–6.CrossRefGoogle Scholar
  53. 53.
    Mittal RK, Holloway R, Dent J. Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects. Gastroenterology. 1995;109(5):1547–54.CrossRefGoogle Scholar
  54. 54.
    Math MV, Khadkikar RM, Kattimani YR. Honey—a nutrient with medicinal property in reflux. Indian J Med Res. 2013;138(6):1020–1.PubMedCentralGoogle Scholar
  55. 55.
    Vemulapalli R. Diet and lifestyle modifications in the management of gastroesophageal reflux disease. Nutr Clin Pract : official publication of the American Society for Parenteral and Enteral Nutrition. 2008;23(3):293–8.CrossRefGoogle Scholar
  56. 56.
    Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting—a population-based study. Aliment Pharmacol Ther. 2003;17(9):1115–24.PubMedCrossRefGoogle Scholar
  57. 57.
    Fass R, Achem SR. Noncardiac chest pain: epidemiology, natural course and pathogenesis. J Neurogastroenterol Motility. 2011;17(2):110–23.CrossRefGoogle Scholar
  58. 58.
    Schey R, Villarreal A, Fass R. Noncardiac chest pain: current treatment. Gastroenterol Hepatol. 2007;3(4):255–62.Google Scholar
  59. 59.
    Pimentel M, Bonorris GG, Chow EJ, Lin HC. Peppermint oil improves the manometric findings in diffuse esophageal spasm. J Clin Gastroenterol. 2001;33(1):27–31.PubMedCrossRefGoogle Scholar
  60. 60.
    • Khalaf MHG, Chowdhary S, Elmunzer BJ, Elias PS, Castell D. Impact of peppermint therapy on dysphagia and non-cardiac chest pain: a pilot study. Dig Dis Sci. 2019. A retrospective analysis of 36 patients treated with peppermint oil for dysphagia and/or non-cardiac chest pain found that 24 (63%) had symptom improvement. The presence of a well-defined esophageal motility disorder was associated with a relatively higher rate of symptom improvement. Google Scholar
  61. 61.
    Banovcin P, Duricek M, Zatko T, Liptak P, Hyrdel R, Kollarik M. The infusion of menthol into the esophagus evokes cold sensations in healthy subjects but induces heartburn in patients with gastroesophageal reflux disease (GERD). Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2019.Google Scholar
  62. 62.
    Macpherson H, Dumville JC. Acupuncture as a potential treatment for non-cardiac chest pain—a survey. Acupunct Med: journal of the British Medical Acupuncture Society. 2007;25(1–2):18–21.CrossRefGoogle Scholar
  63. 63.
    Dickman R, Schiff E, Holland A, Wright C, Sarela SR, Han B, et al. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn. Aliment Pharmacol Ther. 2007;26(10):1333–44.PubMedCrossRefGoogle Scholar
  64. 64.
    Zhu J, Guo Y, Liu S, Su X, Li Y, Yang Y, et al. Acupuncture for the treatment of gastro-oesophageal reflux disease: a systematic review and meta-analysis. Acupunct Med : journal of the British Medical Acupuncture Society. 2017;35(5):316–23.CrossRefGoogle Scholar
  65. 65.
    Arora AS, Katzka DA. How do I handle the patient with noncardiac chest pain? Clin Gastroenterol Hepatol : the official clinical practice journal of the American Gastroenterological Association. 2011;9(4):295–304 quiz e35.CrossRefGoogle Scholar
  66. 66.
    Borjesson M, Pilhall M, Eliasson T, Norssell H, Mannheimer C, Rolny P. Esophageal visceral pain sensitivity: effects of TENS and correlation with manometric findings. Dig Dis Sci. 1998;43(8):1621–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Internal MedicineThomas Jefferson UniversityPhiladelphiaUSA
  2. 2.Division of GastroenterologyUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations